Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
3
×
life sciences
national blog main
new york blog main
san diego blog main
3
×
san diego top stories
startups
boston blog main
clinical trials
fda
ipo
melinta therapeutics
national top stories
new york top stories
san francisco blog main
san francisco top stories
abbvie
acetylon pharmaceuticals
achaogen
adams street partners
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
ambys medicines
amunix
anirvan ghosh
antibiotics
astrazeneca
beta lactamase inhibitor
biogen
biomedical advanced research and development authority (barda)
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cell therapy
What
medicines
3
×
deal
acquisitions
aiming
ambys
announced
bacteria
big
bio
biopharma
biotech
business
ceo
collabs
company
control
covid
daniel
deadly
debuted
disease
diseases
drug
exited
fighting
formed
future
gilead
gilead’s
help
infections
infectious
introduce
ipo
launch
launches
liver
make
melinta
month
Language
unset
Current search:
deals
×
medicines
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?